DigestRedComo funciona
Red
/
Empresas
Ga
No verificado

Galderma

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaSaludSanidad

57 Comunicados de prensa

Ver todos los comunicados de prensa
20/07/2026
Biotecnología
Farmacéutica
Salud
Sanidad
Industria
Galderma Launches Alastin® in Japan and Key Markets Across Asia Pacific, Expanding Its Footprint in the Region
Fuente
Galderma
Editor
Business Wire
1.00
0
07/07/2026
Multimedia
Salud
Sanidad
Ciencia
Biotecnología
Análisis de Mercados
Industria
Landmark Global Galderma Survey Shows 9 out of 10 People Are Affected by Skin Quality Concerns
Fuente
Galderma
Editor
Business Wire
1.00
0
11/06/2026
Multimedia
Análisis de Mercados
Industria
Biotecnología
Farmacéutica
Salud
Medicina - Varios
Galderma Unveils New Global Survey Data Exploring the Evolving Expectations and Experiences of Patients and Healthcare Professionals With Anti-wrinkle Treatments
Fuente
Galderma
Editor
Business Wire
1.00
0
22/05/2026
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch
Fuente
Galderma
Editor
Business Wire
1.00
0
16/04/2026
Industria
Biotecnología
Farmacéutica
Salud
Medicina - Varios
Galderma Launches New Alastin Regenerating Skin Nectar with TriHex+™, Powered by Its Next-Generation TriHex Technology® Regenerative Platform
Fuente
Galderma
Editor
Business Wire
1.00
0
09/04/2026
Industria
Salud
Ir de compras
Fitness
Medicina - Varios
Farmacéutica
Biotecnología
Interim Data From Two Ongoing Investigator-initiated Trials Highlight the Role of Sculptra® and Restylane® in Addressing Aesthetic Changes Associated With Weight Loss Medications and Menopause
Fuente
Galderma
Editor
Business Wire
1.00
0
07/04/2026
Industria
Biotecnología
Salud
Cosmética
Venta al público/Minorista
Farmacéutica
Galderma Debuts ALASTIN Signature Practices in Partnership With Leading Aesthetic Practices to Elevate Regenerative, Peri-Procedural Skincare
Fuente
Galderma
Editor
Business Wire
1.00
0
24/03/2026
Eventos
Industria
Ciencia
Técnica
Higiene alimentaria
Medicina - Varios
Biotecnología
Sanidad
Farmacéutica
Salud
AAD 2026: Galderma Showcases Latest Evidence Supporting Its Full-Spectrum, Science-Driven Solutions for Diverse Skin Needs
Fuente
Galderma
Editor
Business Wire
1.00
0
23/03/2026
Multimedia
Industria
Cosmética
Venta al público/Minorista
Salud
Higiene alimentaria
Sanidad
Farmacéutica
Biotecnología
Galderma Receives U.S. FDA Approval for Restylane® Contour™ for the Correction of Temple Hollowing
Fuente
Galderma
Editor
Business Wire
1.00
0
20/03/2026
Web y redes sociales
Mercado laboral
Acciones y Obligaciones
Cosmética
Venta al público/Minorista
Salud
Sanidad
Galderma Publishes Invitation and Agenda for Its 2026 Annual General Meeting
Fuente
Galderma
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0